ReviewCancers2023
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma.
Devendra Kumar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewCancers2023
Devendra Kumar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.